Antidepressant medications have an onset of action of several weeks and have moderate efficacy. Their mode of administration is oral (p.o.). Some clinicians wondered whether intravenous (i.v.) administration would speed onset of action and increase efficacy. In this article we review controlled stud
Antidepressants and memory: A review
โ Scribed by P. J. Thompson
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 998 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
โฆ Synopsis
Antidepressant medications have been in general use since the late 1950s. Many patients are treated as outpatients and often continue with their normal routines during treatment. Individuals may undertake activities where any change in memory functioning, negative or positive, might have important consequences. Furthermore, many antidepressants have similar efficacy. Information about differential effects upon memory would seem valuable information for the clinician to have at his or her disposal. This paper reviews available evidence on the effects of antidepressants on human memory. Many studies have involved the single or short-term administration of antidepressants to healthy volunteers, thereby not acknowledging that depression per se has a negative impact on memory processes. Even in the studies on patient samples, groups vary with regard to type and severity of depression, dosage and duration of treatment. Limited evidence, however, does suggest that antidepressants may exert differential effects upon memory functioning which could be predicted from their action on specific neurotransmitter system.
๐ SIMILAR VOLUMES
## In an era of constrained health care financing, clinicians are increasingly faced with considering the economic consequences in addition to the clinical outcomes associated with initiating a patient on antidepressant therapy. This has increased the demand for health economic studies comparing ant
## Abstract The objective of this study was to determine effect sizes for both antidepressant treatment and placebo for depression in Parkinson's disease (PD), and to compare the findings with those reported in elderly depressed patients without PD. Recent reviews have concluded that there is littl
The ยฎrst generation of antidepressants largely act as `dual' action drugs in that they facilitate both noradrenergic and serotonergic activity either by blocking the reuptake of noradrenaline and serotonin (tricyclic antidepressants) or by inhibiting the catabolism of these amines (monoamine oxidase
## Abstract ## Objectives Effects of escitalopram 10โ20โmg/day and mirtazapine 30โ45โmg/day on verbal memory of 18 healthy participants were assessed in a randomized, doubleโblind, placeboโcontrolled, threeโway crossover trial. ## Method Each treatment period lasted for 15 days and was separated